MGC Pharma have broken into the $11b American skin care market after achieving US Food and Drug Administration approval for their “MGC Derma” cosmetics line manufactured from medical cannabis. They recently secured the notoriously hard to get FDA approval giving them the right to market their products into all US states and they have already secured a 1.2m Euro order.
25/05/2016 - 08:01
MGC Pharma breaks into $11b US skin care market with Cannabis line
By Matt Birney
25/05/2016 - 08:01
Related Data & Insights
-
-
Rank Company Revenue th Argent BioPharma $1.7m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
03 Oct 2024
Citation Resources row continues
25 Mar 2024
Javelin to target Goldfields uranium anomaly
01 Mar 2024
Board Moves March 1, 2024
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX